Forbes January 13, 2021
Victoria Forster

The outbreak of the SARS-CoV2 coronavirus that began slowly in Wuhan, China a year ago, before quickly enveloping the world has had widespread, devastating effects on lives, livelihoods and entire economies. Although much focus has rightly centered on the impressive scientific research directly tackling the pandemic, including work tracking the virus, trialing treatments for Covid-19 and developing vaccines, the impact on many other areas of medical research have been less documented and may take several years to fully come to terms with.

Cancer, for example, is the second leading cause of death in the U.S., with the American Cancer Society projecting over 600,000 cancer deaths in 2020. Despite a raging Covid-19 pandemic, this is roughly a quarter of a million...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article